IQM (IQMX) Q2 2026 earnings review
Massive Backlog Surge Validates Commercialization, But H2 Ramp Carries Extreme Execution Risk
IQM's first earnings as a public company present a textbook deep-tech profile: massive forward indicators offset by heavy current operating losses. The headline is an explosive jump in order backlog, adding EUR 33.0M in just one month to break EUR 102.1M by early August. However, H1 2026 revenue of just EUR 8.9M against an operating loss of EUR 60.5M highlights the cash intensity of scaling quantum hardware. Management's FY26 revenue guidance of EUR 42-47M dictates that roughly 80% of the year's revenue must be generated in the second half. A robust cash balance of EUR 309.4M provides runway into 2028, buying the company critical time to execute its aggressive H2 delivery schedule.
🐂 Bull Case
The company added EUR 33M to its backlog in a single month (July), driving total backlog past EUR 102M. This signals strong market acceptance of on-premise quantum infrastructure, anchored by major wins like the CSC LUMI AI Factory integration.
With EUR 309.4M in cash following the dual listing, IQM has secured its financial runway through mid-2028. This removes near-term dilution risk while funding critical EUR 40M fab expansions.
🐻 Bear Case
Hitting the EUR 44.5M revenue midpoint requires generating ~EUR 35.6M in H2—a 4x increase over H1. Hardware deliveries are notoriously prone to supply chain and calibration delays.
An operating loss of EUR 60.5M on just EUR 8.9M in revenue underscores the massive R&D and manufacturing overhead required before reaching any semblance of unit economic profitability.
⚖️ Verdict: ⚪
Neutral/Constructive. The commercial validation is exceptional, and the cash position is bulletproof for the next 24 months. However, investors should brace for potential lumpiness in revenue recognition given the steep H2 delivery requirements.
Key Themes
Explosive Backlog Growth & Sovereign Demand
The single most important metric in the release is the jump in order backlog. Closing H1 at EUR 69.1M, the company added a staggering EUR 33.0M by August 3. This is driven by a macro shift toward sovereign compute infrastructure and strategic enterprise adoption, highlighted by the integration of an IQM computer into the LUMI AI Factory (CSC).
Fab Expansion Removing Production Bottlenecks
To service the massive backlog, IQM is investing over EUR 40M to expand its proprietary fab. This will double cleanroom capacity and enable the production of up to 30 full-stack quantum computers annually. This physical infrastructure expansion is the primary driver for translating backlog into recognized revenue over the next 12-24 months.
Strategic AI & HPC Integrations
IQM is aggressively moving away from standalone quantum systems into hybrid environments. Collaborations with NVIDIA (using the Ising family of AI models for parallel qubit calibration to improve uptime) and HPE (integrating with Cray HPC infrastructure) are critical drivers for making the hardware commercially viable for enterprise customers.
Extreme Back-Loaded Revenue Curve
The data contradicts a smooth growth narrative. With EUR 8.9M generated in H1 and full-year guidance of EUR 42-47M, management is relying on H2 to deliver roughly 80% of the year's revenue. In hardware manufacturing, where site preparation, shipping, and calibration can take months, this presents a massive execution and timing risk. Any slippage into 2027 will result in a significant FY26 revenue miss.
Intense Operating Cash Burn
An operating loss of EUR 60.5M in H1 is alarming when compared to the revenue base. While the EUR 309.4M cash pile provides safety through Q2 2028, the company is burning roughly EUR 10M per month. Profitability is entirely dependent on future operating leverage that has not yet been demonstrated.
Technological Arms Race
While IQM noted significant advancements in error correction, specifically introducing 'barbell codes' (a novel family of qLDPC error correction codes customized for the Constellation topology), quantum computing remains a highly speculative technological race. Obsolescence risk remains high if well-capitalized U.S. competitors achieve fault tolerance faster.
Other KPIs
Reflects the heavy upfront costs of R&D, global expansion (Japan, Spain), and scaling up cleanroom manufacturing capacity. The loss eclipses H1 revenue (EUR 8.9M) by nearly 7x, typical for pre-scale deep tech, but establishes a high bar for future margin requirements.
A fortress balance sheet following the public listing. Management explicitly stated this provides financial runway into Q2 2028, allowing the company to fund its EUR 40M fab expansion without returning to equity markets in the near term.
Guidance
Accelerating dramatically. With only EUR 8.9M recognized in H1, the midpoint of EUR 44.5M implies EUR 35.6M in H2. This requires flawless execution of manufacturing and on-premise installation in Q3 and Q4.
Stable to Accelerating. Given the massive EUR 33M added to the backlog in July alone, hitting the EUR 70M midpoint for the full year looks highly achievable, and potentially conservative, depending on the timing of other sovereign infrastructure deals in the pipeline.
Key Questions
Visibility into H2 Deliveries
Given that H2 requires roughly a 400% increase in revenue compared to H1 to meet guidance, what percentage of the implied EUR 35.6M H2 revenue is already physically built, shipped, or in final calibration?
Margin Profile of New Backlog
With the backlog surging past EUR 102M, how should we model the gross margin profile of these systems as the new fab capacity comes online, compared to the highly bespoke initial 17 systems?
Pace of Fab Expansion
The EUR 40M investment to reach a 30-system-per-year capacity is critical. What is the precise timeline for when this new cleanroom capacity becomes fully operational and yields deliverable systems?